Genes & biomarkers
HER2 / ERBB2 results
ERBB2 · HER2 · IHC / ISH / mutation
Protein expression, gene amplification and gene variants are different findings.
Sources checked · Introductory guide
On this page
What does this result mean?
HER2 is the protein encoded by ERBB2. IHC assesses protein expression; ISH assesses gene amplification. These differ from ERBB2 variants identified by sequencing.[1]
How does it connect to treatment?
Criteria for trastuzumab or trastuzumab deruxtecan depend on the cancer and test finding. HER2-low breast cancer and HER2-mutant lung cancer do not share a single positivity rule.[2]
What should I check in my report?
Check the IHC score, ISH result and ERBB2 variant separately. If told “HER2 negative,” ask whether the report meets a low-expression category relevant to a particular treatment.
Questions for your care team
- Does my HER2 result describe expression, amplification or a variant?
- Which treatments or trials fit my cancer type, stage and previous treatment?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- MedlinePlus · HER2 Tumor Marker Test (opens in a new tab)
- NCI · Fam-Trastuzumab Deruxtecan-nxki (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.